Sampre Nutritions Ltd. (INE375C01014) has reached a significant milestone with the ex-date for its recently announced corporate actions, including a 1:1 bonus issue and a stock split. These strategic moves are designed to enhance market liquidity and potentially make the stock more accessible to a broader range of investors.

Key Corporate Actions

Impact on Shareholders

Shareholders who owned Sampre Nutritions shares as of November 10, 2023, are set to benefit from these corporate actions. Here's how the changes will affect existing shareholders:

It's important to note that while the number of shares will increase, the overall investment value remains unchanged. The bonus issue effectively doubles the number of shares held, while the stock split further subdivides each share.

Recent Stock Performance

Sampre Nutritions has shown remarkable performance in the stock market recently:

Implications of Corporate Actions

These corporate actions by Sampre Nutritions may have several implications:

1. Increased Liquidity: The higher number of outstanding shares could potentially lead to increased trading volume and liquidity in the market.

2. Broader Investor Base: The reduced per-share price following the split may make the stock more attractive to retail investors, potentially broadening the company's investor base.

3. Market Perception: Such actions are often viewed positively by the market, as they may signal management's confidence in the company's future prospects.

However, investors should note that these corporate actions do not inherently change the fundamental value of their holdings or the company itself. The total value of an investor's stake in the company remains the same, just divided among more shares.

As always, investors are advised to consider their individual financial goals and risk tolerance when making investment decisions, and to consult with financial advisors if needed.

Sampre Nutritions Limited , a key player in the nutritional products sector, has reported a profitable second quarter for the fiscal year 2025-26 and announced plans for equity share issuance to its promoters. The company's Board of Directors approved both standalone and consolidated unaudited financial results for Q2 and H1 FY2025-26, along with a significant move to convert existing unsecured loans into equity.

Financial Performance

For the quarter ended September 30, 2025, Sampre Nutritions reported the following key financial metrics on a standalone basis:

The company's performance shows a significant improvement compared to the same period last year, with a substantial increase in both revenue and profitability.

Equity Share Issuance

In a strategic move, the Board of Directors has approved the issuance of equity shares to promoters through the conversion of existing unsecured loans. The key details of this preferential allotment are:

• Number of shares to be issued: 1,770,710 equity shares
• Face value: ₹5 per share
• Issue price: ₹42 per share
• Total value of conversion: Approximately ₹7.44 crore

The beneficiaries of this allotment are:

1. Brahma Gurbani: To receive 1,693,880 shares
2. Meera Gurbani: To receive 76,830 shares

This move is expected to strengthen the company's balance sheet by reducing debt and increasing equity capital.

Impact on Shareholding Structure

Post-allotment, the shareholding structure of the promoters will change as follows:

The company plans to convene an Extraordinary General Meeting to obtain member approval for this preferential allotment.

Sampre Nutritions' strong financial performance and strategic capital restructuring indicate the company's focus on growth and financial stability. Investors and stakeholders will be keenly watching how these moves translate into long-term value creation for the company.

Note: All financial figures are based on standalone results unless otherwise specified.